Public Health Modeling News

Instead of drugs that must be taken daily, scientists are closing in on longer-acting alternatives — perhaps even a future in which H.I.V. may require attention just twice a year, inconceivable in the darkest decades of the epidemic. Featuring Yale School of Public Health's Gregg Gonsalves.

A multidisciplinary team of Yale scientists has received a $4-million federal grant to study the effectiveness of a new vaccine and monoclonal antibody shot designed to prevent respiratory syncytial virus (RSV) in infants.

The profound impact of climate change on community health was the topic of the 2024 Connecticut Symposium on Climate Change and Health at the Yale School of Public Health.

Yale Cancer Center (YCC) and Smilow Cancer Hospital physicians and scientists will share new data for breakthrough and emerging cancer treatments as well as new discoveries in obesity, tobacco, evolution, and early onset cancers in early April at the American Association for Cancer Research (AACR) annual meeting.

Most analyses regarding the excess risk of death during the COVID-19 pandemic have relied on summary data. However, a recent study published in the International Journal of Epidemiology instead analyzed individual patient-level data based on medical records from the largest integrated healthcare system in the United States.

Population aging constitutes a crucial driver for future heat- and cold-related deaths.

The 2022 outbreak of mpox, previously known as monkeypox, was curbed in large part by drastic changes in behavior among gay and bisexual men, and not by vaccination, according to a new analysis published on Thursday in the journal Cell.

A new study published in Nature Medicine finds that emergency admissions, and even deaths, are higher than expected for days and weeks after storms. YSPH Assistant Professor of Epidemiology (Environmental Health Sciences) Kai Chen comments.

Dr. Jeffrey Townsend on Yale Cancer Answers.